Search Results 471-480 of 19056 for creatine

1. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   ... creatinine clearance ≥ 50 mL/min at screening. Adequate electrolytes at Baseline, defined as serum potassium and magnesium levels within institutional ...

2. A Study to Assess Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer - Mayo Clinic

   Creatinine ≤ 1.4 mg/dL;; Total bilirubin ≤ 3.0 mg/dL;; Aspartate transaminase (AST) ≤ x upper limit of normal (ULN);; Alanine transaminase (ALT) ≤ 3 x ULN ...

3. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   ... creatinine > 120 µmol/L). History of severe hypersensitivity to blood or plasma derived products, or any component of the PANZYGA. Known immunoglobulin A ...

4. Phase IIB Study Of PHENOGENE-1A (Cromolyn) As An Adjuvant Therapy In Mild To Moderate ALS - Mayo Clinic

   Moderate-to-severe renal disease: creatinine clearance \<45 mL/min/1.73 m2 (by Cockcroft-Gault calculation). 14. Any clinically significant disorder or ...

5. Accelerated vs Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours - Mayo Clinic

   Adequate renal function with estimated creatinine clearance of ≥ 60 ml/min according to the Cockcroft-Gault formula, unless calculated to be < 60 ml/min or ...

6. Costs - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

   Serum creatinine; eGFR; Urine test; Blood pressure check; Nephrologist consultation. Coronary Heart Disease, None. Lipid and Lp(a) levels; Carotid ultrasound ...

7. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

   Creatinine clearance ≥ 30 mL/min/1.73 m^2 (as determined by Cockcroft-Gault equation); Negative serum pregnancy test done ≤ 7 days prior to registration ...

8. Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough - Mayo Clinic

   Serum creatinine, total bilirubin, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 2x the upper limit of normal (ULN) during screening ...

9. Study to Analyze Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

   Required Initial Laboratory Values ≤120 days prior to registration Serum Creatinine ≤ 2.0 mg/dL . AST or ALT ≤ 3 x upper limit of normal (ULN). Exclusion ...

10. Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) - Mayo Clinic

    Serum creatinine greater than or equal to 1.5 x ULN or known active kidney disease that may affect drug pharmacokinetics (e.g., nephrotic syndrome); Presence ...